Aligos Therapeutics (ALGS) Other financing activities (2019 - 2025)
Aligos Therapeutics' (ALGS) quarterly Other financing activities came in at $124000.0 in Q4 2025, down 10.79% YoY from $139000.0 in Q4 2024, and down 10.79% on a QoQ basis from $139000.0 in Q4 2024.
Aligos Therapeutics (ALGS) Other financing activities (2019 - 2025) Analysis & Trends
Aligos Therapeutics (ALGS) has 7 years of Other financing activities data on file, last reported at $124000.0 in Q4 2025.
- Quarterly Other financing activities fell 10.79% year-over-year to $124000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $263000.0 (up 14.85% YoY) and the FY2025 annual result came in at $304000.0, down 30.28% from the prior year.
- Other financing activities declined to $124000.0 in Q4 2025, from $139000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $438000.0 in Q2 2023 to a low of -$91000.0 in Q3 2022.
- A 5-year average of $112166.7 and a median of $98500.0 in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2021 — Other financing activities soared 433.33% — and 2022, when it tumbled 605.56%.
- Tracing ALGS's Other financing activities over 5 years: stood at $18000.0 in 2021, then surged by 927.78% to $185000.0 in 2022, then tumbled by 51.35% to $90000.0 in 2023, then soared by 54.44% to $139000.0 in 2024, then dropped by 10.79% to $124000.0 in 2025.
- The last three Other financing activities figures came in at $124000.0 (Q4 2025), $139000.0 (Q4 2024), and $90000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Aligos Therapeutics | 67.75 Mn | 37.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 124,000.00 |
| Dec 31, 2025 | 124,000.00 |
| Dec 31, 2024 | 139,000.00 |
| Dec 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Jun 30, 2023 | 438,000.00 |
| Jun 30, 2023 | 438,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 185,000.00 |
| Dec 31, 2022 | 185,000.00 |
| Sep 30, 2022 | -91,000.00 |
| Sep 30, 2022 | -91,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Sep 30, 2021 | 18,000.00 |